Larché M - Search Results

1

Investigating T cell activation and tolerance in vivo: peptide challenge in allergic asthmatics.

Smith TR, Larché M. Smith TR, et al. Among authors: larche m. Cytokine. 2004 Oct 21;28(2):49-54. doi: 10.1016/j.cyto.2004.07.001. Cytokine. 2004. PMID: 15381180 Review.

2

Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.

Smith TR, Alexander C, Kay AB, Larché M, Robinson DS. Smith TR, et al. Among authors: larche m. Allergy. 2004 Oct;59(10):1097-101. doi: 10.1111/j.1398-9995.2004.00601.x. Allergy. 2004. PMID: 15355469 Clinical Trial.

3

Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches.

Larché M. Larché M. Pharmacol Ther. 2005 Dec;108(3):353-61. doi: 10.1016/j.pharmthera.2005.05.004. Epub 2005 Jul 12. Pharmacol Ther. 2005. PMID: 16014312 Review.

4

Anti-T-cell strategies in the treatment of allergic disease.

Larché M. Larché M. Allergy. 2002;57 Suppl 72:20-3. doi: 10.1034/j.1398-9995.57.s72.9.x. Allergy. 2002. PMID: 12144549

5

Peptide immunotherapy.

Larché M. Larché M. Immunol Allergy Clin North Am. 2006 May;26(2):321-32, viii. doi: 10.1016/j.iac.2006.02.005. Immunol Allergy Clin North Am. 2006. PMID: 16701147 Review.

6

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects.

Oldfield WL, Kay AB, Larché M. Oldfield WL, et al. Among authors: larche m. J Immunol. 2001 Aug 1;167(3):1734-9. doi: 10.4049/jimmunol.167.3.1734. J Immunol. 2001. PMID: 11466398 Clinical Trial.

7

Tregs and allergic disease.

Robinson DS, Larché M, Durham SR. Robinson DS, et al. Among authors: larche m. J Clin Invest. 2004 Nov;114(10):1389-97. doi: 10.1172/JCI23595. J Clin Invest. 2004. PMID: 15545986 Free PMC article. Review.

8

Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1.

Haselden BM, Syrigou E, Jones M, Huston D, Ichikawa K, Chapman MD, Kay AB, Larché M. Haselden BM, et al. Among authors: larche m. J Allergy Clin Immunol. 2001 Sep;108(3):349-56. doi: 10.1067/mai.2001.117461. J Allergy Clin Immunol. 2001. PMID: 11544452

9

The potential of peptide immunotherapy in allergy and asthma.

Ali FR, Kay AB, Larché M. Ali FR, et al. Among authors: larche m. Curr Allergy Asthma Rep. 2002 Mar;2(2):151-8. doi: 10.1007/s11882-002-0010-5. Curr Allergy Asthma Rep. 2002. PMID: 11892095 Review.

10

Peptide-based vaccines in the treatment of specific allergy.

Alexander C, Kay AB, Larché M. Alexander C, et al. Among authors: larche m. Curr Drug Targets Inflamm Allergy. 2002 Dec;1(4):353-61. doi: 10.2174/1568010023344562. Curr Drug Targets Inflamm Allergy. 2002. PMID: 14561182 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page